Oral glucocorticoids plus PPIs raise osteoporotic fracture risk in patients with RAJanuary 6, 2021Rheumatoid Arthritis
Tocilizumab + methotrexate vs. tocilizumab alone for preventing radiographic progression in RAJanuary 6, 2021Rheumatoid Arthritis
Prognostic factors for short-term mortality in RA patients admitted to ICUJanuary 6, 2021Rheumatoid Arthritis
Gut microbiome influences response to methotrexate in new-onset RA patientsJanuary 6, 2021Rheumatoid Arthritis
Perceived distress linked to inflammatory arthritis among at-risk individualsJanuary 6, 2021Rheumatoid Arthritis
ANA measurement before TNFi therapy could help predict treatment failure in RAJanuary 6, 2021Rheumatoid Arthritis
Baricitinib favorable for long-term treatment of moderate to severe RAJanuary 6, 2021Rheumatoid Arthritis
Early treatment response may predict sustained DMARD-free remission in RAJanuary 6, 2021Rheumatoid Arthritis
Rheumatology NewsEULAR recommendations define strategies to improve adherence in RMDsJanuary 4, 2021Lupus & Connective Tissue DiseasesRheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisPediatricsOsteoporosisOsteoarthritis
Rheumatology News"Lipid paradox” seen in nonobese RA patients with low LDLDecember 28, 2020Rheumatoid Arthritis
Rheumatology NewsGut microbiome influences response to methotrexate in new-onset RA patientsDecember 21, 2020Rheumatoid Arthritis
Rheumatology NewsOral steroids plus PPIs increase osteoporotic fracture risk in RA patientsDecember 17, 2020OsteoporosisRheumatoid Arthritis
Rheumatology NewsBaricitinib combo for COVID-19 accelerates recovery, study showsDecember 14, 2020COVID-19 UpdatesRheumatoid Arthritis
Rheumatology NewsAdvent of biologics extended life expectancy but also expenses for RA patientsDecember 9, 2020Rheumatoid Arthritis
Rheumatology NewsTNF inhibitor–induced psoriasis treatment algorithm maintains TNF inhibitor if possibleNovember 25, 2020Psoriatic ArthritisRheumatoid Arthritis
